op Business Intelligence and Analytics Tools Organizations

‘Justice Intelligence’ Startup Darrow Expands Plaintiff-Finding Service to Mass Arbitrations

On Wednesday, New York and Tel Aviv-based legal tech startup Darrow announced the addition of mass arbitration to its PlaintiffLink service. Publicly launched in February 2024, PlaintiffLink helps firms connect with and review potential plaintiffs for cases. The development and expansion of PlaintiffLink was likely supported in part by the startup’s $35 million Series B funding round, which it announced in September 2023.

Marketing itself as a justice intelligence platform, Darrow essentially looks to be a business development tool for litigation teams. Some of its offerings use generative AI to analyze and scan public data, such as SEC filings and consumer complaints, to find viable class action and litigation opportunities.

‘Justice Intelligence’ Startup Darrow Expands Plaintiff-Finding Service to Mass Arbitrations

‘s Top Business Intelligence and Analytics Tools Organizations

On Wednesday, New York and Tel Aviv-based legal tech startup Darrow announced the addition of mass arbitration to its PlaintiffLink service. Publicly launched in February 2024, PlaintiffLink helps firms connect with and review potential plaintiffs for cases. The development and expansion of PlaintiffLink was likely supported in part by the startup’s $35 million Series B funding round, which it announced in September 2023.

Marketing itself as a justice intelligence platform, Darrow essentially looks to be a business development tool for litigation teams. Some of its offerings use generative AI to analyze and scan public data, such as SEC filings and consumer complaints, to find viable class action and litigation opportunities.

Healthcare Business Intelligence Market Size to Reach USD 27.63 Billion By 2032, With a Growing CAGR of 14% | Research by SNS Insider

SNS Insider pvt ltd

Top Business Intelligence Trends In
Top Business Intelligence Trends In

The rise in electronic health records (EHRs) and the integration of big data analytics in healthcare have further propelled the adoption of BI solutions.

Pune, Aug. 14, 2024 (GLOBE NEWSWIRE) — Healthcare Business Intelligence Market Size & Share:

“According to SNS Insider Research, The Healthcare Business Intelligence (BI) Market Size was valued at US$ 9.0 Billion in 2023 and is expected to reach US$ 27.63 Billion by 2032 and grow at a CAGR of 14.0% over the forecast period 2024-2032.”

Business Intelligence (BI) is well-funded in the modern software-as-a-service market. BI utilizes big data to analyze various aspects of business, uncover new profit centers, and simulate potential developments. The market growth is driven by the increasing number of patient registries, as well as technological advancements in the pharmaceutical sector. An article published by Frontiers in August 2022 highlights patient registries as a crucial data source for healthcare practices, drug utilization, and clinical outcomes. Patient registries provide epidemiological data, and standards of care, and help in overcoming patient confidentiality issues, particularly for rare diseases. This anticipated growth in patient registries is also expected to drive the uptake of health business intelligence.

Top Business Intelligence Trends for — Broscorp
Top Business Intelligence Trends for — Broscorp

The healthcare BI market is growing rapidly due to the government’s initiative to increase the adoption of Electronic Health Records (EHR) and the proliferation of patient registries along with big data usage in healthcare. According to an article published by the Biomedical Journal of Scientific & Technical Research in 2021, the government is digitalizing healthcare services by incorporating EHR for better patient data management and to facilitate coordination among healthcare providers. The government is also introducing national-level policies, such as the National Digital Health Blueprint, to ensure a single digital health record across India. Additionally, institutions like Tata Memorial Hospital and Max Hospitals Private Limited have implemented electronic medical records (EMR) systems and plan to transition to EHR systems. The widespread implementation of BI across the healthcare industry, alongside its associated benefits, is expected to further drive market expansion.

Get a Sample Report of Healthcare Business Intelligence (BI) Market@ https://www.snsinsider.com/sample-request/2089

Major Players Listed in this Report are:

Healthcare Business Intelligence (BI) Market Report Scope:

Report Attributes

Details

Market Size in 2023

US$ 9.0 Billion

Market Size by 2032

US$ 27.63 Billion

CAGR

CAGR of 14.0% From 2024 to 2032

Base Year

2023

Forecast Period

2024-2032

Historical Data

2020-2022

Key Regional Coverage

North America (US, Canada, Mexico), Europe (Eastern Europe [Poland, Romania, Hungary, Turkey, Rest of Eastern Europe] Western Europe] Germany, France, UK, Italy, Spain, Netherlands, Switzerland, Austria, Rest of Western Europe]), Asia Pacific (China, India, Japan, South Korea, Vietnam, Singapore, Australia, Rest of Asia Pacific), Middle East & Africa (Middle East [UAE, Egypt, Saudi Arabia, Qatar, Rest of Middle East], Africa [Nigeria, South Africa, Rest of Africa], Latin America (Brazil, Argentina, Colombia, Rest of Latin America)

Key Growth Drivers

•The Increasing Integration of EHR Systems Across Healthcare Facilities Is Driving the Demand for Business Intelligence (BI) Tools that can Analyze Large Volumes of Patient Data, Improve Decision-Making, and Enhance Patient Outcomes.•The Shift Towards Value-Based Care and Personalized Medicine has Led to an Increased Focus on Healthcare Analytics. Bi Tools are Crucial in Analyzing Patient Data, Predicting Trends, And Enabling More Effective Management of Resources and Treatments.

Do you have any specific queries or need any customization research or data on Healthcare Business Intelligence (BI) Market, Make an Enquiry Now@ https://www.snsinsider.com/enquiry/2089

Segmentation Dynamics

In 2023, healthcare payers held the largest revenue share at 40%. Market growth is being driven by the increasing need to enhance provider networks, the implementation of various healthcare business intelligence (BI) tools to reduce operational costs, and rising competition among payers. Additionally, the growing emphasis on increasing memberships and minimizing fraud claims is pushing payers to adopt BI solutions to manage their operational expenses more effectively.

During the forecast period, the healthcare manufacturers segment is expected to experience significant market growth. The large number of pharmaceutical and medical device manufacturers in both developed and emerging economies has been contributing to rapid revenue generation. Meanwhile, healthcare manufacturers are increasingly turning to SaaS software to reduce maintenance and development costs, which is anticipated to further drive the market.

Furthermore, customer analytics tools such as direct marketing and Customer Relationship Management (CRM) dashboards are helping various vendors, including hospitals, government bodies, and employers’ private exchangers, to become more efficient in terms of revenue growth and cost savings. This, in turn, is expected to drive the uptake of business intelligence tools by vendors.

Healthcare Business Intelligence (BI) Market Key Segmentation:

By Component

By Mode of Delivery

On-premise

Cloud-based

Hybrid

By Application

Financial Analysis

Operational Analysis

Clinical Analysis

Patient Care

By End User

Payers

Providers

Healthcare Manufacturers

Regional Insights

North America accounted for the largest revenue share of 48% in 2023, mainly due to the increased implementation of BI solutions and services in healthcare aiming to offer enhanced patient care. The presence of large manufacturing hubs and reduced expenses are also key factors driving regional growth. Additionally, the constant upgrading of healthcare and IT infrastructure, along with increased adoption of cloud computing, has contributed to the growth. In 2023, the U.S. accounted for the highest revenue share in the North American market due to its high adoption of advanced BI technology, changing analytics protocols, easy availability of BI infrastructure, and a professional BIG data crowd.

On the other hand, Asia Pacific is expected to be the most lucrative regional market in the forecast period due to increasing awareness about BI tools among healthcare providers and organizations, driven by government initiatives. The regional market growth is also attributed to the increased penetration of mobile-based solutions and the implementation of technologically advanced BI solutions in countries including India, China, and Japan.

Recent Developments

In June 2022, Oracle Corporation acquired Cerner Corporation, a provider of health information technology services.

In January 2022, PINC AI, the technology and services platform of Premier Inc., launched its latest release called INsights. This revamped healthcare self-service solution is designed to provide personalized, on-demand analytics.

Buy a Single-User PDF of Healthcare Business Intelligence (BI) Market Analysis & Outlook Report 2024-2032@ https://www.snsinsider.com/checkout/2089

Key Takeaways

Healthcare payers had the largest market share 40% in 2023, focusing on reducing operational costs and building provider networks.

North America accounted for the largest share of revenue 48% in 2023, attributed to a mature business intelligence market and well-established healthcare infrastructure.

Growth is being driven by an increasing prevalence of chronic diseases and the need for patient-centric continuous monitoring.

Table of Contents – Major Key Points

1. Introduction

2. Executive Summary

3. Research Methodology

4. Market Dynamics Impact Analysis

5. Statistical Insights and Trends Reporting

6. Competitive Landscape

7. Healthcare Business Intelligence (BI) Market Segmentation, by Component

8. Healthcare Business Intelligence (BI) Market Segmentation, by Application

9. Healthcare Business Intelligence (BI) Market Segmentation, by End User

10. Healthcare Business Intelligence (BI) Market Segmentation, by Mode of Delivery

11. Regional Analysis

12. Company Profiles

13. Use Cases and Best Practices

14. Conclusion

Access Complete Report Details of Healthcare Business Intelligence (BI) Market Analysis 2024-2032@ https://www.snsinsider.com/reports/healthcare-business-intelligence-bi-market-2089

[For more information or need any customization research mail us at info@snsinsider.com]

About Us:

SNS Insider is one of the leading market research and consulting agencies that dominates the market research industry globally. Our company’s aim is to give clients the knowledge they require in order to function in changing circumstances. In order to give you current, accurate market data, consumer insights, and opinions so that you can make decisions with confidence, we employ a variety of techniques, including surveys, video talks, and focus groups around the world.

CONTACT: Contact Us: Akash Anand – Head of Business Development & Strategy info@snsinsider.com Phone: +1-415-230-0044 (US) | +91-7798602273 (IND)
Growth in Brand Investments Across European Football Leagues More Than Doubles in 2023-24

Single-club partnerships dominate as 88% of brands opt for exclusive deals

STAMFORD, Conn., Aug. 14, 2024 /PRNewswire/ — SponsorUnited, the leading global sports and entertainment intelligence platform—tracking over 386,000 brands, 2.1 million deals, and 17.6 million data points across sports, entertainment, media, and talent, today released its European Football Marketing Partnerships 2023–24 report.

SponsorUnited, unrivaled sponsorship data for brands and rights holders (PRNewsfoto/SponsorUnited)

Key findings include:

Significant growth in brand and sponsorship deals: The number of brand sponsors in European football grew by 22% this season, more than doubling last season’s increase. In comparison, the five major professional sports leagues in the US averaged a 10.5% increase in sponsorship deals since 2022. This impressive growth in European football was driven by a combination of new deals and improved retention of existing deals, resulting in a record-breaking total of almost 6,000 deals. This represents a 20% increase in deals from the previous season, along with an 11% decrease in churn rate of deals.

Surge in exclusive single-club partnerships: Nearly 90% of brands (88%) have signed single-club deals over multi-club partnerships, a trend evident this season with over 3,800 different brands committing to just one football club each. This is a 23% increase from last season. This trend is also led by the aforementioned categories, which together account for one third of all single-club deals. Additionally, this year Serie A and LALIGA clubs have surpassed Premier League clubs in sponsorship deals with nearly 1,500 and 1,450 deals each— emphasizing the strategic focus on deepened market penetration and fan engagement.

“The dramatic rise in European football partnerships this season underscores an evolution in the market dynamics,” said Bob Lynch, founder and CEO of SponsorUnited. “Non-traditional sectors like business services and construction are increasingly engaging with the sport, reflecting a maturation in how brands and leagues collaborate. These sectors often start with targeted, single-team investments, which can scale significantly as they realize the value of their engagements, setting the stage for long-term impacts on club and athlete partnerships.”

Most-endorsed athletes shift following major departures: With the departures of Neymar Jr., Lionel Messi, and Cristiano Ronaldo from the “Big 5” leagues, the endorsement landscape for European football athletes has dramatically shifted. Goalkeeper Guillermo Ochoa now leads with 19 endorsements; however, he is also departing the Big 5 after this season. Vinicius Junior (“Vini Jr.”) and Harry Kane follow with 17 and 16 endorsements respectively, with Vini Jr. adding the most deals (5). Son Heung-min, Robert Lewandowski, Erling Haaland, and Virgil van Dijk each have 14 endorsements. They are followed by Jack Grealish with 13 and Thomas Müller with 12.

Top growing teams showcase remarkable follower growth: The top five growing teams have significantly outpaced follower growth across all teams, with Real Madrid CF leading with an addition of 54M followers. This surge in popularity is closely tied to the presence of high-profile players such as Vini Jr., who is among the most-endorsed athletes this season. FC Bayern Munich, Liverpool, and Manchester City, which have also shown substantial increases, adding 31M, 30M, and 26M followers respectively, are home to other top-endorsed athletes like Harry Kane, Virgil van Dijk, and Erling Haaland. This trend underscores the strong correlation between a team’s social media growth and the endorsement appeal of its star players.

Coca-Cola leads sponsorship deals amid diverse brand categories: With 39 deals, Coca-Cola still leads the list of European football sponsors, followed by EA Sports (FC) (33 deals), eToro (31 deals), Sorare (25 deals), and Skechers (23 deals). When it comes to brand categories, construction remains a powerhouse with nearly 800 sponsorships—a 27% increase from last season and a 54% increase from the season before. They are followed by auto with 425 (+38%) and tech with 415 (+23%) deals.

“The increasing influence of US ownership in European football is reshaping business practices and commercial strategies across the leagues,” added Lynch. “This transatlantic investment is fostering deeper engagements with US brands, who are now more confident in entering and expanding within the European market through innovative avenues.”

View the full report here.

About SponsorUnitedLaunched in 2018, SponsorUnited is the leading global sports and entertainment intelligence platform, delivering actionable data and insights to build stronger marketing partnerships. We provide unrivaled knowledge across the sponsorship and media landscape so our clients can make impactful decisions that drive business.

With over 386,000 brands, 2.1 million deals, and 17.6 million data points across sports, entertainment, media, and talent, our SaaS database enables brands, rights holders, and agencies to partner more effectively. By delivering real-time trends, on-demand research, and the most comprehensive data available, we connect the entire sponsorship ecosystem and are rewriting the partnership playbook.

SponsorUnited was ranked on the Inc. 5000—the most prestigious list of the fastest-growing private companies in America—in both 2022, 2023, and 2024. Visit https://sponsorunited.com/ to learn more and discover exclusive data and insights to make intelligent partnership decisions at speed and scale.

CONTACT: Lisa Brown, lbrown@sponsorunited.com

Cision

View original content to download multimedia:https://www.prnewswire.com/news-releases/growth-in-brand-investments-across-european-football-leagues-more-than-doubles-in-202324-302222889.html

SOURCE SponsorUnited

POET Technologies Reports Second Quarter 2024 Financial Results

TORONTO, Aug. 14, 2024 (GLOBE NEWSWIRE) — POET Technologies Inc. (“POET” or the “Company”) (TSX Venture: PTK; NASDAQ: POET), the designer and developer of the POET Optical Interposer™, Photonic Integrated Circuits (PICs) and light sources for the data center, tele-communication and artificial intelligence markets, today reported its unaudited condensed consolidated financial results as at and for the three months ended June 30, 2024. The Company’s financial results as well as the Management’s Discussion and Analysis have been filed on SEDAR. All financial figures are in United States dollars (“USD”) unless otherwise indicated.

Second Quarter and Recent Business Highlights:

The Company announced a major design win with Foxconn Interconnect Technology (FIT) to supply 800G and 1.6T optical engines for FIT pluggable modules that address the growth in demand for cutting-edge AI applications and high-speed data center networks. FIT’s parent, Foxconn, is the world’s largest electronics contract manufacturer and a major supplier of components and assemblies.Based on the exceptional performance of modules incorporating POET’s high-speed optical engines, Luxshare Tech, a preferred supplier to Apple, announced that it is expanding its portfolio of optical modules targeted at AI networks using POET’s optical engines.POET was selected as winner of the “Best Optical AI Solution” award in the seventh annual AI Breakthrough Awards program conducted by AI Breakthrough, a leading market intelligence organization that recognizes the top companies, technologies and products in the global Artificial Intelligence (AI) market today.During the second quarter, the Company raised $15 million in equity capital in two non-brokered private placements with two institutional investors by issuing 6,706,665 Units at an average price of $2.24 per Unit. Each Unit consists of one common share and one common share purchase warrant with each warrant exercisable into one common share for a period of five years from the issue date at $3.20 per share.Through the use of its ATM facility during the month of April 2024, the Company raised gross proceeds of $7,447,000 from the issuance of 4,592,739 common shares at an average price of $1.62 per common share.Subsequent to the end of the quarter, the Company raised an additional $10 million in a non-brokered registered direct offering to a single institutional investor by issuing 3,333,334 Units at $3.00 per Unit. Each Unit consists of one common share and one common share purchase warrant with each warrant exercisable into one common share for a period of five years from the issue date at $4.00 per share.The Company’s cash balance as of June 30, 2024 was $21.3 million; as of July 31, 2024, the Company had cash and cash equivalents of approximately $28.7 million and working capital of $27 million. There are 65,596,234 issued and outstanding common shares.

Management Comments“We are gratified to have been chosen to supply our advanced high-speed integrated optical engine chips to two of the world’s largest producers of electronic and photonic components and systems serving the leading AI networks and AI network service providers,” said Dr. Suresh Venkatesan, Chairman & CEO. “We are also grateful to investors who share our confidence and optimism over the future of our Company. By raising the amount of capital that we have in the past few months, we have significantly lowered the risk to achieving sustainable revenues. Further, we were honored to be recognized by AI Breakthrough, a top market intelligence organization, as the winner of the ‘Best Optical AI Solution for 2024’. This accolade not only highlights our innovative efforts but also affirms that we are on the right track both technologically and commercially.”

Non-IFRS Financial SummaryThe Company reported non-recurring engineering revenue (“NRE”) of nil in the second quarter of 2024 compared to $177,000 for the same period in 2023 and $8,710 in the first quarter of 2024 Historically, the Company provided NRE services to multiple customers for projects utilizing the unique capabilities of the POET Optical Interposer platform. No billable NRE services were provided in Q2 2024.

The Company reported a net loss of $8.0 million, or ($0.14) per share, in the second quarter of 2024 compared with a net loss of $4.4 million, or ($0.11) per share, for the same period in 2023 and a net loss of $5.7 million, or ($0.13) per share, in the first quarter of 2024. The net loss in the second quarter of 2024 included research and development costs of $2.1 million compared to $2.0 million for the same period in 2023 and $1.9 million in the first quarter of 2024. Fluctuations in R&D for a Company of this size and this stage of growth are expected on a period-over-period basis as the Company transitions from technology development to product development.

Non-cash expenses in the second quarter of 2024 included stock-based compensation of $1.6 million and depreciation and amortization of $0.5 million. Non-cash stock-based compensation and depreciation and amortization in the same period of 2023 were $0.7 million and $0.5 million, respectively. First quarter 2024 stock-based compensation and depreciation and amortization were $0.9 million and $0.5 million, respectively. The Company had non-cash finance costs of $20,000 in the second quarter of 2024 compared to non-cash finance costs of $11,000 in the second quarter of 2023 and non-cash costs of $20,000 in the first quarter of 2024.

The Company recognized other income, including interest of $175,000 in the second quarter of 2024, compared to $57,000 in the same period in 2023 and $53,000 in the first quarter of 2024.

The Company reported non-cash fair value adjustment to derivative warrant liability of $1.4 million in the second quarter of 2024, compared to nil in the same period in 2023 and $0.6 million in the first quarter of 2024. This non-cash item relates to warrants issued in a foreign currency and is periodically remeasured.

Cash flow from operating activities in the second quarter of 2024 was ($4.5) million, compared to ($3.2) million in the second quarter of 2023 and ($4.6) million in the first quarter of 2024.

Raised gross proceeds of $35.7 million, including $10 million in July, through the issuance of units from multiple private placements, issuance of common shares using its ATM and the issuance of common shares from the exercise of warrants.

Non-IFRS Financial Performance MeasuresCertain financial information presented in this press release is not prescribed by IFRS. These non-IFRS financial performance measures are included because management has used the information to analyze the business performance and financial position of POET. These non-IFRS financial measures are intended to provide additional information only and do not have any standardized meaning under IFRS and may not be comparable to similar measures presented by other companies. These non-IFRS financial measures should not be considered in isolation or as a substitute for measures of performance prepared in accordance with IFRS.

POET TECHNOLOGIES INC.PROFORMA – NON-IFRS AND IFRS PRESENTATION OF OPERATIONS(All figures are in U.S. Dollars) For the Quarter ended:30-Jun-24 31-Mar-24 31-Dec-23 30-Sep-23 30-Jun-23             Revenue- 8,710 107,551 – 177,390 Research and development(2,117,828)(1,922,066)(2,142,003)(2,043,264)(2,036,953)Depreciation and amortization(509,699)(509,260)(505,869)(508,484)(462,743)Professional fees(366,839)(409,726)(902,368)(273,905)(255,094)Wages and benefits(780,146)(768,496)(676,539)(640,241)(655,066)Impact of join venture- – – – – Stock-based compensation(1,591,741)(947,502)(1,050,088)(1,251,648)(697,690)General expenses and rent(1,390,933)(570,819)(317,333)(429,457)(502,707)Derivative liability adjustment(1,376,761)(629,824)(24,865)- – Interest expense(20,833)(19,753)(13,547)(34,890)(11,214)Other (income), including interest174,911 52,558 54,047 45,448 57,454 Net loss(7,979,869)(5,716,178)(5,471,014)(5,136,441)(4,386,623)      Net loss per share(0.14)(0.13)(0.13)(0.13)(0.11)

ATM Quarterly UpdateDuring the fiscal quarter ended June 30, 2024, through the ATM, the Company sold 4,592,739 common shares at an average price of C$2.22 per share. The Company received gross proceeds of C$10,202,164, less aggregate cash commissions paid to Craig-Hallum of C$306,065 resulting in net proceeds of C$9,896,099. The common shares were sold on the Nasdaq Capital Markets and the sales were denominated in USD. The values disclosed are based on the average Bank of Canada exchange rate applicable during the reporting period.

About POET Technologies Inc.POET is a design and development company offering high-speed optical modules, optical engines and light source products to the artificial intelligence systems market and to hyperscale data centers.  POET’s photonic integration solutions are based on the POET Optical Interposer™, a novel, patented platform that allows the seamless integration of electronic and photonic devices into a single chip using advanced wafer-level semiconductor manufacturing techniques. POET’s Optical Interposer-based products are lower cost, consume less power than comparable products, are smaller in size and are readily scalable to high production volumes. In addition to providing high-speed (800G, 1.6T and above) optical engines and optical modules for AI clusters and hyperscale data centers, POET has designed and produced novel light source products for chip-to-chip data communication within and between AI servers, the next frontier for solving bandwidth and latency problems in AI systems.  POET’s Optical Interposer platform also solves device integration challenges in 5G networks, machine-to-machine communication, self-contained “Edge” computing applications and sensing applications, such as LIDAR systems for autonomous vehicles.  POET is headquartered in Toronto, Canada, with operations in Allentown, PA, Shenzhen, China, and Singapore.  More information about POET is available on our website at www.poet-technologies.com.

Media Relations Contact:Adrian BrijbassiAdrian.brijbassi@poet.tech               Company Contact:Thomas R. Mika, EVP & CFOtm@poet.tech

Forward-Looking StatementsThis news release contains “forward-looking information” (within the meaning of applicable Canadian securities laws) and “forward-looking statements” (within the meaning of the U.S. Private Securities Litigation Reform Act of 1995). Such statements or information are identified with words such as “anticipate”, “believe”, “expect”, “plan”, “intend”, “potential”, “estimate”, “propose”, “project”, “outlook”, “foresee” or similar words suggesting future outcomes or statements regarding any potential outcome. Such statements include the Company’s expectations with respect to the success of the Company’s product development efforts, the performance of its products, the expected results of its operations, meeting revenue targets, and the expectation of continued success in the financing efforts, the capability, functionality, performance and cost of the Company’s technology as well as the market acceptance, inclusion and timing of the Company’s technology in current and future products and expectations for approval of proposals at the Company’s annual meeting of shareholders.

Such forward-looking information or statements are based on a number of risks, uncertainties and assumptions which may cause actual results or other expectations to differ materially from those anticipated and which may prove to be incorrect. Assumptions have been made regarding, among other things, management’s expectations regarding the success and timing for completion of its development efforts, the introduction of new products, financing activities, future growth, recruitment of personnel, opening of offices, the form and potential of its joint venture, plans for and completion of projects by the Company’s consultants, contractors and partners, availability of capital, and the necessity to incur capital and other expenditures. Actual results could differ materially due to a number of factors, including, without limitation, the failure of its products to meet performance requirements, lack of sales in its products, once released, operational risks in the completion of the Company’s anticipated projects, lack of performance of its joint venture, risks affecting the Company’s ability to execute projects, the ability of the Company to generate sales for its products, the ability to attract key personnel, the ability to raise additional capital and the agreement by shareholders to approve proposals put forth by the Company at shareholders’ meetings. Although the Company believes that the expectations reflected in the forward-looking information or statements are reasonable, prospective investors in the Company’s securities should not place undue reliance on forward-looking statements because the Company can provide no assurance that such expectations will prove to be correct. Forward-looking information and statements contained in this news release are as of the date of this news release and the Company assumes no obligation to update or revise this forward-looking information and statements except as required by law.

Neither TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.120 Eglinton Avenue, East, Suite 1107, Toronto, ON, M4P 1E2- Tel: 416-368-9411 – Fax: 416-322-5075

Healthcare Business Intelligence Market Size to Reach USD 27.63 Billion By 2032, With a Growing CAGR of 14% | Research by SNS Insider

SNS Insider pvt ltd

The rise in electronic health records (EHRs) and the integration of big data analytics in healthcare have further propelled the adoption of BI solutions.

Pune, Aug. 14, 2024 (GLOBE NEWSWIRE) — Healthcare Business Intelligence Market Size & Share:

“According to SNS Insider Research, The Healthcare Business Intelligence (BI) Market Size was valued at US$ 9.0 Billion in 2023 and is expected to reach US$ 27.63 Billion by 2032 and grow at a CAGR of 14.0% over the forecast period 2024-2032.”

Business Intelligence (BI) is well-funded in the modern software-as-a-service market. BI utilizes big data to analyze various aspects of business, uncover new profit centers, and simulate potential developments. The market growth is driven by the increasing number of patient registries, as well as technological advancements in the pharmaceutical sector. An article published by Frontiers in August 2022 highlights patient registries as a crucial data source for healthcare practices, drug utilization, and clinical outcomes. Patient registries provide epidemiological data, and standards of care, and help in overcoming patient confidentiality issues, particularly for rare diseases. This anticipated growth in patient registries is also expected to drive the uptake of health business intelligence.

The healthcare BI market is growing rapidly due to the government’s initiative to increase the adoption of Electronic Health Records (EHR) and the proliferation of patient registries along with big data usage in healthcare. According to an article published by the Biomedical Journal of Scientific & Technical Research in 2021, the government is digitalizing healthcare services by incorporating EHR for better patient data management and to facilitate coordination among healthcare providers. The government is also introducing national-level policies, such as the National Digital Health Blueprint, to ensure a single digital health record across India. Additionally, institutions like Tata Memorial Hospital and Max Hospitals Private Limited have implemented electronic medical records (EMR) systems and plan to transition to EHR systems. The widespread implementation of BI across the healthcare industry, alongside its associated benefits, is expected to further drive market expansion.

Get a Sample Report of Healthcare Business Intelligence (BI) Market@ https://www.snsinsider.com/sample-request/2089

Major Players Listed in this Report are:

Healthcare Business Intelligence (BI) Market Report Scope:

Report Attributes

Details

Market Size in 2023

US$ 9.0 Billion

Market Size by 2032

US$ 27.63 Billion

CAGR

CAGR of 14.0% From 2024 to 2032

Base Year

2023

Forecast Period

2024-2032

Historical Data

2020-2022

Key Regional Coverage

North America (US, Canada, Mexico), Europe (Eastern Europe [Poland, Romania, Hungary, Turkey, Rest of Eastern Europe] Western Europe] Germany, France, UK, Italy, Spain, Netherlands, Switzerland, Austria, Rest of Western Europe]), Asia Pacific (China, India, Japan, South Korea, Vietnam, Singapore, Australia, Rest of Asia Pacific), Middle East & Africa (Middle East [UAE, Egypt, Saudi Arabia, Qatar, Rest of Middle East], Africa [Nigeria, South Africa, Rest of Africa], Latin America (Brazil, Argentina, Colombia, Rest of Latin America)

Key Growth Drivers

•The Increasing Integration of EHR Systems Across Healthcare Facilities Is Driving the Demand for Business Intelligence (BI) Tools that can Analyze Large Volumes of Patient Data, Improve Decision-Making, and Enhance Patient Outcomes.•The Shift Towards Value-Based Care and Personalized Medicine has Led to an Increased Focus on Healthcare Analytics. Bi Tools are Crucial in Analyzing Patient Data, Predicting Trends, And Enabling More Effective Management of Resources and Treatments.

Do you have any specific queries or need any customization research or data on Healthcare Business Intelligence (BI) Market, Make an Enquiry Now@ https://www.snsinsider.com/enquiry/2089

Segmentation Dynamics

In 2023, healthcare payers held the largest revenue share at 40%. Market growth is being driven by the increasing need to enhance provider networks, the implementation of various healthcare business intelligence (BI) tools to reduce operational costs, and rising competition among payers. Additionally, the growing emphasis on increasing memberships and minimizing fraud claims is pushing payers to adopt BI solutions to manage their operational expenses more effectively.

During the forecast period, the healthcare manufacturers segment is expected to experience significant market growth. The large number of pharmaceutical and medical device manufacturers in both developed and emerging economies has been contributing to rapid revenue generation. Meanwhile, healthcare manufacturers are increasingly turning to SaaS software to reduce maintenance and development costs, which is anticipated to further drive the market.

Furthermore, customer analytics tools such as direct marketing and Customer Relationship Management (CRM) dashboards are helping various vendors, including hospitals, government bodies, and employers’ private exchangers, to become more efficient in terms of revenue growth and cost savings. This, in turn, is expected to drive the uptake of business intelligence tools by vendors.

Healthcare Business Intelligence (BI) Market Key Segmentation:

By Component

By Mode of Delivery

On-premise

Cloud-based

Hybrid

By Application

Financial Analysis

Operational Analysis

Clinical Analysis

Patient Care

By End User

Payers

Providers

Healthcare Manufacturers

Regional Insights

North America accounted for the largest revenue share of 48% in 2023, mainly due to the increased implementation of BI solutions and services in healthcare aiming to offer enhanced patient care. The presence of large manufacturing hubs and reduced expenses are also key factors driving regional growth. Additionally, the constant upgrading of healthcare and IT infrastructure, along with increased adoption of cloud computing, has contributed to the growth. In 2023, the U.S. accounted for the highest revenue share in the North American market due to its high adoption of advanced BI technology, changing analytics protocols, easy availability of BI infrastructure, and a professional BIG data crowd.

On the other hand, Asia Pacific is expected to be the most lucrative regional market in the forecast period due to increasing awareness about BI tools among healthcare providers and organizations, driven by government initiatives. The regional market growth is also attributed to the increased penetration of mobile-based solutions and the implementation of technologically advanced BI solutions in countries including India, China, and Japan.

Recent Developments

In June 2022, Oracle Corporation acquired Cerner Corporation, a provider of health information technology services.

In January 2022, PINC AI, the technology and services platform of Premier Inc., launched its latest release called INsights. This revamped healthcare self-service solution is designed to provide personalized, on-demand analytics.

Buy a Single-User PDF of Healthcare Business Intelligence (BI) Market Analysis & Outlook Report 2024-2032@ https://www.snsinsider.com/checkout/2089

Key Takeaways

Healthcare payers had the largest market share 40% in 2023, focusing on reducing operational costs and building provider networks.

North America accounted for the largest share of revenue 48% in 2023, attributed to a mature business intelligence market and well-established healthcare infrastructure.

Growth is being driven by an increasing prevalence of chronic diseases and the need for patient-centric continuous monitoring.

Table of Contents – Major Key Points

1. Introduction

2. Executive Summary

3. Research Methodology

4. Market Dynamics Impact Analysis

5. Statistical Insights and Trends Reporting

6. Competitive Landscape

7. Healthcare Business Intelligence (BI) Market Segmentation, by Component

8. Healthcare Business Intelligence (BI) Market Segmentation, by Application

9. Healthcare Business Intelligence (BI) Market Segmentation, by End User

10. Healthcare Business Intelligence (BI) Market Segmentation, by Mode of Delivery

11. Regional Analysis

12. Company Profiles

13. Use Cases and Best Practices

14. Conclusion

Access Complete Report Details of Healthcare Business Intelligence (BI) Market Analysis 2024-2032@ https://www.snsinsider.com/reports/healthcare-business-intelligence-bi-market-2089

[For more information or need any customization research mail us at info@snsinsider.com]

About Us:

SNS Insider is one of the leading market research and consulting agencies that dominates the market research industry globally. Our company’s aim is to give clients the knowledge they require in order to function in changing circumstances. In order to give you current, accurate market data, consumer insights, and opinions so that you can make decisions with confidence, we employ a variety of techniques, including surveys, video talks, and focus groups around the world.

CONTACT: Contact Us: Akash Anand – Head of Business Development & Strategy info@snsinsider.com Phone: +1-415-230-0044 (US) | +91-7798602273 (IND)
‘Justice Intelligence’ Startup Darrow Expands Plaintiff-Finding Service to Mass Arbitrations

On Wednesday, New York and Tel Aviv-based legal tech startup Darrow announced the addition of mass arbitration to its PlaintiffLink service. Publicly launched in February 2024, PlaintiffLink helps firms connect with and review potential plaintiffs for cases. The development and expansion of PlaintiffLink was likely supported in part by the startup’s $35 million Series B funding round, which it announced in September 2023.

Marketing itself as a justice intelligence platform, Darrow essentially looks to be a business development tool for litigation teams. Some of its offerings use generative AI to analyze and scan public data, such as SEC filings and consumer complaints, to find viable class action and litigation opportunities.

‘Justice Intelligence’ Startup Darrow Expands Plaintiff-Finding Service to Mass Arbitrations

On Wednesday, New York and Tel Aviv-based legal tech startup Darrow announced the addition of mass arbitration to its PlaintiffLink service. Publicly launched in February 2024, PlaintiffLink helps firms connect with and review potential plaintiffs for cases. The development and expansion of PlaintiffLink was likely supported in part by the startup’s $35 million Series B funding round, which it announced in September 2023.

Marketing itself as a justice intelligence platform, Darrow essentially looks to be a business development tool for litigation teams. Some of its offerings use generative AI to analyze and scan public data, such as SEC filings and consumer complaints, to find viable class action and litigation opportunities.

Leave a Comment